UY35274A - COMPOUNDS AND METHODS TO TREAT BACTERIAL INFECTIONS - Google Patents
COMPOUNDS AND METHODS TO TREAT BACTERIAL INFECTIONSInfo
- Publication number
- UY35274A UY35274A UY0001035274A UY35274A UY35274A UY 35274 A UY35274 A UY 35274A UY 0001035274 A UY0001035274 A UY 0001035274A UY 35274 A UY35274 A UY 35274A UY 35274 A UY35274 A UY 35274A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- bacterial infections
- methods
- treat bacterial
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000035143 Bacterial infection Diseases 0.000 title abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Se describen compuestos de fórmula (I), sus sales farmacéuticamente aceptables y usos de los compuestos de fórmula (I) para tratar infecciones bacte rianasCompounds of formula (I), their pharmaceutically acceptable salts and uses of the compounds of formula (I) to treat bacterial infections are described.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361755537P | 2013-01-23 | 2013-01-23 | |
| US201361859910P | 2013-07-30 | 2013-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY35274A true UY35274A (en) | 2014-07-31 |
Family
ID=50033593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001035274A UY35274A (en) | 2013-01-23 | 2014-01-23 | COMPOUNDS AND METHODS TO TREAT BACTERIAL INFECTIONS |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US8889671B2 (en) |
| EP (1) | EP2948461B1 (en) |
| JP (1) | JP6285960B2 (en) |
| KR (1) | KR102149567B1 (en) |
| CN (1) | CN105229012B (en) |
| AR (1) | AR094565A1 (en) |
| AU (1) | AU2014208965B2 (en) |
| BR (1) | BR112015017519B1 (en) |
| CA (1) | CA2897887C (en) |
| CY (1) | CY1122805T1 (en) |
| DK (1) | DK2948461T3 (en) |
| EA (1) | EA026901B1 (en) |
| ES (1) | ES2780824T3 (en) |
| HR (1) | HRP20200401T1 (en) |
| HU (1) | HUE048990T2 (en) |
| IL (1) | IL239860A0 (en) |
| LT (1) | LT2948461T (en) |
| ME (1) | ME03676B (en) |
| MX (1) | MX360650B (en) |
| MY (1) | MY192765A (en) |
| NZ (1) | NZ710091A (en) |
| PH (1) | PH12015501588B1 (en) |
| PL (1) | PL2948461T3 (en) |
| PT (1) | PT2948461T (en) |
| RS (1) | RS60078B1 (en) |
| SG (1) | SG11201505462YA (en) |
| SI (1) | SI2948461T1 (en) |
| SM (1) | SMT202000261T1 (en) |
| TW (1) | TWI603973B (en) |
| UY (1) | UY35274A (en) |
| WO (1) | WO2014114929A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9040528B2 (en) * | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| US8889671B2 (en) * | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
| SG11201609404SA (en) * | 2014-05-29 | 2016-12-29 | Entasis Therapeutics Ltd | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| WO2017075573A1 (en) * | 2015-10-29 | 2017-05-04 | University Of Maryland, College Park | Compositions and methods for inhibition of bacterial infections in human endocervix |
| CN106632298B (en) | 2015-11-03 | 2021-06-01 | 上海科胜药物研发有限公司 | Preparation method and intermediate of tedizolid |
| WO2018222795A1 (en) | 2017-06-01 | 2018-12-06 | Bristol-Myers Squibb Company | Substituted nitrogen containing compounds |
| CN109111466B (en) * | 2017-06-22 | 2022-08-02 | 中国科学院上海药物研究所 | Benzisoxazole spiropyrimidine triones compound, preparation method and application thereof |
| CN109111465B (en) * | 2017-06-22 | 2021-01-12 | 中国科学院上海药物研究所 | Thiazolidone spiropyrimidine trione compound and preparation method and application thereof |
| WO2018233670A1 (en) * | 2017-06-22 | 2018-12-27 | 中国科学院上海药物研究所 | Benzoisoxazole spiropyrimidine compound, preparation method and use thereof |
| CN108060207B (en) * | 2017-12-29 | 2021-10-15 | 河南科技大学 | A minimum bactericidal concentration determination method based on trace natural compounds |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| FI3833665T3 (en) | 2018-08-09 | 2023-10-09 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| CN111559985A (en) * | 2020-05-13 | 2020-08-21 | 河南科技大学第一附属医院 | Oxazolone compounds with bactericidal effect and preparation method thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0759570B2 (en) | 1986-05-06 | 1995-06-28 | 三井東圧化学株式会社 | Method for producing 2-oxazolidinones |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| EP1664052B1 (en) | 2003-08-15 | 2009-02-18 | AstraZeneca AB | Fused heterocycles as inhibitors of glutamate racemase (muri) |
| WO2005066119A2 (en) | 2003-12-31 | 2005-07-21 | Schering-Plough Ltd. | Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols and preparation thereof |
| EP1888597A2 (en) | 2005-05-09 | 2008-02-20 | Warner-Lambert Company LLC | Antibacterial agents |
| DOP2006000268A (en) | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | ANTIBACTERIAL AGENTS |
| CL2007003332A1 (en) * | 2006-11-24 | 2008-06-20 | Actelion Pharmaceuticals Ltd | COMPOUNDS DERIVED FROM CONDENSED HETEROCICLES; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE PREVENTION OR TREATMENT OF BACTERIAL INFECTIONS. |
| JP2010531868A (en) | 2007-07-02 | 2010-09-30 | アストラゼネカ アクチボラグ | 3-Spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents |
| EP2350077B1 (en) * | 2008-10-14 | 2016-01-27 | Entasis Therapeutics Limited | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US8889671B2 (en) * | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
-
2014
- 2014-01-21 US US14/159,773 patent/US8889671B2/en active Active
- 2014-01-22 CA CA2897887A patent/CA2897887C/en active Active
- 2014-01-22 WO PCT/GB2014/050164 patent/WO2014114929A1/en not_active Ceased
- 2014-01-22 HR HRP20200401TT patent/HRP20200401T1/en unknown
- 2014-01-22 RS RS20200292A patent/RS60078B1/en unknown
- 2014-01-22 PT PT147026421T patent/PT2948461T/en unknown
- 2014-01-22 LT LTEP14702642.1T patent/LT2948461T/en unknown
- 2014-01-22 MY MYPI2015001807A patent/MY192765A/en unknown
- 2014-01-22 ES ES14702642T patent/ES2780824T3/en active Active
- 2014-01-22 BR BR112015017519-8A patent/BR112015017519B1/en active IP Right Grant
- 2014-01-22 HU HUE14702642A patent/HUE048990T2/en unknown
- 2014-01-22 NZ NZ710091A patent/NZ710091A/en unknown
- 2014-01-22 DK DK14702642.1T patent/DK2948461T3/en active
- 2014-01-22 SI SI201431524T patent/SI2948461T1/en unknown
- 2014-01-22 KR KR1020157022580A patent/KR102149567B1/en active Active
- 2014-01-22 EP EP14702642.1A patent/EP2948461B1/en active Active
- 2014-01-22 JP JP2015554245A patent/JP6285960B2/en active Active
- 2014-01-22 MX MX2015009479A patent/MX360650B/en active IP Right Grant
- 2014-01-22 SM SM20200261T patent/SMT202000261T1/en unknown
- 2014-01-22 ME MEP-2020-55A patent/ME03676B/en unknown
- 2014-01-22 PL PL14702642T patent/PL2948461T3/en unknown
- 2014-01-22 SG SG11201505462YA patent/SG11201505462YA/en unknown
- 2014-01-22 EA EA201591362A patent/EA026901B1/en unknown
- 2014-01-22 AU AU2014208965A patent/AU2014208965B2/en active Active
- 2014-01-22 CN CN201480017715.6A patent/CN105229012B/en active Active
- 2014-01-23 TW TW103102537A patent/TWI603973B/en active
- 2014-01-23 AR ARP140100208A patent/AR094565A1/en active IP Right Grant
- 2014-01-23 UY UY0001035274A patent/UY35274A/en not_active Application Discontinuation
- 2014-10-16 US US14/515,684 patent/US9187495B2/en active Active
-
2015
- 2015-07-09 IL IL239860A patent/IL239860A0/en active IP Right Grant
- 2015-07-20 PH PH12015501588A patent/PH12015501588B1/en unknown
- 2015-10-13 US US14/881,595 patent/US9540394B2/en active Active
-
2016
- 2016-11-16 US US15/353,325 patent/US9839641B2/en active Active
-
2020
- 2020-03-12 CY CY20201100217T patent/CY1122805T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY35274A (en) | COMPOUNDS AND METHODS TO TREAT BACTERIAL INFECTIONS | |
| CR20150472A (en) | USE OF PIRAZOLOPIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kd-RELATED DISORDERS | |
| CY1121129T1 (en) | TOY FGFR4 INHIBITORS | |
| MX375970B (en) | TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USES. | |
| UY35485A (en) | HETEROCYCLIC COMPOUNDS AND USES OF THE SAME | |
| DOP2017000078A (en) | INDAZOLS REPLACED WITH BENCILO AS INHIBITORS OF BUB1. | |
| JOP20140114B1 (en) | Heterocyclic compounds and their uses | |
| EA201692203A1 (en) | TANK-BINDING KINAZ INHIBITING COMPOUNDS | |
| UY34632A (en) | OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME | |
| UY34750A (en) | ? COMPOUNDS FOR HIV TREATMENT, COMPOSITIONS, PREPARATION METHODS, INTERMEDIARIES AND THERAPEUTIC METHODS ?. | |
| CR20140464A (en) | HETEROCICLYL COMPOUNDS | |
| MX2020001757A (en) | COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES. | |
| EA201692219A1 (en) | METHODS OF OBTAINING ANTI-VIRUS COMPOUNDS | |
| UY34657A (en) | ? MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES ?. | |
| EA201790395A1 (en) | AMINOTRIAZIN DERIVATIVES SUITABLE FOR USING AS TANK-BINDING KINASE INHIBITORS | |
| UY34725A (en) | NEW DERIVATIVES OF TIENOPIRIMIDINE, PROCESSES FOR ITS PREPARATION AND ITS THERAPEUTIC USES. | |
| EA201500931A1 (en) | PYRIDIN-4-ILA DERIVATIVES | |
| CL2018001493A1 (en) | New phenyl derivatives | |
| DOP2016000297A (en) | PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT INFECTIOUS DISEASES | |
| BR112017007194A2 (en) | purine hydroxyl compounds and applications thereof | |
| CL2016001623A1 (en) | Benzamide and nicotinamide compounds and methods for using them. | |
| CO2017005732A2 (en) | Dihydropyrimidin-2-one Compounds and Their Medical Uses | |
| DOP2018000049A (en) | COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS | |
| UY34543A (en) | DERIVATIVES OF SULFONYLAMINOPIRROLIDINONE, ITS PREPARATION AND THERAPEUTIC APPLICATION. | |
| DOP2015000176A (en) | AZETIDINYLOXYPHENYLPIRROLIDINE COMPOUNDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20211028 |